Journal List > Korean J Endocr Surg > v.10(4) > 1060016

M.D., M.D., and M.D.: A Study on the Risk Factors for Recurrence of Recurrent Papillary Thyroid Cancer after Surgery

Abstract

Purpose:

Papillary thyroid carcinoma (PTC) is known to have a favorable prognosis and long-term survival due to its biologic characteristics of slow growth and late distant metastasis. However, its characteristic of lymph node metastasis has resulted in a high incidence of neck recurrence and only rare lung metastasis. The objective of this study is to analyze the characteristics of recurrent or persistent thyroid cancer and to evaluate the risk factors for the development of recurrence.

Methods:

We retrospectively reviewed 479 consecutive cases of PTC and these patients had undergone surgical operations from January 2004 to December 2006. We assessed age, gender, the tumor characteristics, the operative methods and the recurrence patterns, and the correlations between these factors and recurrence were analyzed.

Results:

Of the 479 patients with PTC and who were initially treated with surgery at our hospital, 42 patients (8.8%) had recurrent disease. Univariate analysis showed that an age less than 45 years, male gender, extra-thyroidal extension, lymph node metastasis, multifocality, bilaterality and neck node dissection were related to a higher rate of recurrence. Of these, lymph node metastasis and central or lateral neck node dissection were the independent risk factors for recurrent PTC on the multivariate analysis. Conclusion: The significant factors influencing locoregional recurrence and distant metastasis were cervical lymph node metastasis and incomplete neck node dissection. In order to reduce the rate of recurrence of PTC, an exact preoperative evaluation of the nodal status and formal neck node dissection are recommended during the initial surgery in patients who have these factors of recurrence. (Korean J Endocrine Surg 2010;10:261-265)

REFERENCES

1.Oritiz S., Rodriquez JM., Parrilla P., Perez D., Morno-Gallego A., Rios A, et al. Recurrent papillary thyroid cancer: Analysis of prognostic factors including the histological variant. Eur J Surg. 2001. 17:406–12.
2.Micheal C., David T., Harold JW. Recurrent thyroid cancer. Role of surgery versus radioactive iodine. Ann Surg. 1994. 219:588–95.
3.Cady B., Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1998. 104:947–53.
4.Hay ID., Grant CS., Taylor WF., McConahey WM. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a prognostic scoring system. Surgery. 1987. 102:1088–95.
5.Harach HR., Franssila KO., Wasenius VM. Occult papillary carcinoma of the thyroid. A "normal" finding in Finland. A systematic autopsy study. Cancer. 1985. 56:531–8.
crossref
6.Chow SM., Law SC., Chan JK., Au SK., Yau S., Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003. 98:31–40.
crossref
7.Wada N., Duh QY., Sugino K., Iwaski H., Kameyama K., Mimura T, et al. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003. 237:399–407.
8.Martin JS., Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med. 1998. 338:297–306.
crossref
9.Grant CS. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988. 104:954–62.
10.Clark JR., Lai P., Hall F., Borglund A., Eski S., Freeman JL. Variables predicting distant metastasis in thyroid cancer. Laryngoscope. 2005. 115:661–7.
11.Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M. Cancer statistics. CA Cancer J Clin. 2007. 57:43–66.
12.Shah JP., Loree TR., Dharker DD., Strong EW., Begg C., Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992. 164:658–61.
crossref
13.Scheumann GF., Gimm O., Wegener G., Hundeshagen H., Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994. 18:559–67. discussion 67-8.
crossref
14.Shvili Y., Zohar Y., Buller N., Laurian N. Conservative surgical management of invasive differentiated thyroid cancer. J Laryngol Otol. 1985. 99:1255–60.
crossref
15.McCaffrey TV., Bergstralh EJ., Hay ID. Locally invasive thyroid carcinoma. Head Neck. 1994. 16:165–72.
16.Park HL., Kwak JK., Kang SS., Kim DY., Kang HG., Shin JY, et al. The analysis of tumor aggressiveness according to tumor size in occult papillary thyroid carcinoma. J Korean Surg Soc. 2007. 73:470–5.
17.DeGroot LJ., Kaplan EL., Mccormick M., Straus FH. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab. 1990. 71:414–24.
crossref
18.Haigh PI., Urbach DR., Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low-or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005. 12:81–9.
19.Sosa JA., Udelsman R. Total thyroidectomy for differentiated thyroid cancer. J Surg Oncol. 2006. 94:701–7.
crossref
20.Mirallie E., Visset J., Sagan C., Hamy A., Le Bodic MF., Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg. 1999. 23:970–3.
21.Watkinson JC., Franklyn JA., Olliff JF. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer. Thyroid. 2006. 16:187–94.
crossref
22.Marshall CL., Lee JE., Xing Y., Perrier ND., Edeiken BS., Evans DB, et al. Routine pre-operative Ultrasonography for papillary thyroid cancer: effects on cervical recurrence. Surgery. 2009. 146:1063–72.
crossref

Table 1.
Local recurrence according to patient's gender&age
Factors No recurrence, number of patients (%) Recurrence, number of patients (%) P value
Age (years)     0.015
<45 231 (88.2%) 31 (11.8%)  
≥45 206 (94.5%) 11 (5.1%)  
Gender     0.019
Female 396 (92.1%) 33 (7.7%)  
Male 41 (82.0%) 9 (18.0%)  
Table 2.
Local recurrence according to tumor characteristics
Factors No recurrence, number of patients (%) Recurrence, number of patients (%) P value
Size <1 cm 182 (94.8%) 10 (5.2%) 0.073
1∼2 cm 202 (92.7%) 16 (7.3%)  
>2 cm 53 (75.7%) 16 (22.5%)  
ETE∗ Capsular invasion 22 (95.7%) 1 (4.3%) 0.000
Soft tissue 114 (85.7%) 18 (13.5%)  
Organs 4 (57.1%) 3 (42.9%)  
Multifocality     0.003
Solitary 344 (93.2%) 24 (6.5%)  
Multiple 93 (83.8%) 18 (16.2%)  
Bilaterality     0.003
(−) 351 (93.4%) 25 (6.6%)  
(+) 86 (82.7%) 17 (16.5%)  
Lymph node metastasis     0.000
(−) 303 (96.2%) 12 (3.8%)  
(+) 134 (81.2%) 30 (18.3%)  

ETE = extrathyroidal extension.

Table 3.
Local recurrence according to surgery
Surgery No recurrence, number of patients (%) Recurrence, number of patients (%) P value
Thyroidectomy     0.576
Lobectomy 119 (92.2%) 10 (7.8%)  
Total thyroidectomy 318 (90.6%) 32 (9.1%)  
Neck dissection No 59 (90.8%) 6 (9.2%) 0.000
CND∗ 369 (94.6%) 20 (5.1%)  
LND 9 (36.0%) 16 (64.0%)  

CND = central node dissection;

LND = lateral node dissection

Table 4.
Organs showing local recurrence in 42 patients
Loco-regional 42
Lymph node 31
Level IV 11
Level III+IV 10
Level III 6
Others 4
Thyroid 9

Thyroid+lymph node 2

Table 5.
Multivariate analysis of the relationship betwee recurrence and various clinical factors
Factors P value HR∗ 95% confidence interval
Gender 0.116 0.666 0.286∼1.553
Age 0.345 1.859 0.860∼4.019
Size 0.491 1.132 0.796∼1.612
ETE 0.933 0.048 0.000∼6.643
Multifocality 0.251 0.554 0.200∼1.535
Bilaterality 0.818 1.126 0.407∼3.113
Thyroidectomy 0.115 0.263 0.050∼1.380
Neck dissection 0.013 1.289 0.109∼1.766
Lymph node metastas is 0.001 1.233 0.097∼1.559

HR = hazard ratio;

ETE = extrathyroidal extension.

TOOLS
Similar articles